Jubilant Ingrevia Ltd is one of India’s leading specialty chemicals and nutrition companies, known for its strong presence in life science chemicals, specialty intermediates, and nutrition ingredients. The company serves multiple industries including pharmaceuticals, agrochemicals, consumer goods, and nutrition products.
Over the past few years, Jubilant Ingrevia Ltd has expanded its portfolio through innovation, global partnerships, and capacity expansion. Its diversified product mix and strong global demand for specialty chemicals have positioned the company as an important player in India’s growing chemical manufacturing sector.
In this article, we analyze Jubilant Ingrevia Ltd’s share price targets from 2026 to 2030 based on current market data, industry trends, company fundamentals, and long-term sector growth prospects.
| Detail | Value |
|---|---|
| Open | ₹554.95 |
| Previous Close | ₹555.90 |
| Day’s High | ₹564.00 |
| Day’s Low | ₹553.70 |
| VWAP | ₹558.03 |
| 52-Week High | ₹851.80 |
| 52-Week Low | ₹535.20 |
| All-Time High | ₹885.00 |
| All-Time Low | ₹241.30 |
| Market Capitalization | ₹8,930 Cr |
| Volume | 111,483 |
| Value (Lacs) | 625.03 |
| 20D Avg Volume | 1,420,038 |
| 20D Avg Delivery (%) | 6.03% |
| Face Value | ₹1 |
| Book Value Per Share | ₹193.86 |
| Dividend Yield | 0.89% |
| UC Limit | ₹667.05 |
| LC Limit | ₹444.75 |
| Beta | 1.14 |
Jubilant Ingrevia Ltd operates across three major business segments:
Specialty Chemicals
Nutrition & Health Solutions
Life Science Chemicals
The company supplies specialty ingredients and chemical intermediates to global pharmaceutical, nutrition, and agrochemical industries. Its focus on innovation, sustainable manufacturing, and global supply chains has helped it establish a strong market presence.
Jubilant Ingrevia benefits from increasing demand for specialty chemicals and nutritional ingredients worldwide, which positions it well for long-term growth.
Strong Position in Specialty Chemicals
The company manufactures high-value specialty chemical products used in pharmaceuticals, agrochemicals, and industrial applications.
Global Customer Base
Jubilant Ingrevia exports to multiple international markets, reducing dependence on domestic demand.
Growing Nutrition Segment
Its nutrition and health solutions division provides ingredients used in food, animal nutrition, and pharmaceutical products.
Focus on Sustainability
The company invests in environmentally sustainable manufacturing processes and green chemistry solutions.
Diversified Business Model
Operating across multiple chemical segments provides revenue stability and reduces risk from sector-specific fluctuations.
Recent financial performance reflects stable revenue growth supported by global demand for specialty chemicals and nutrition ingredients.
Key observations include:
Increasing demand for life science chemical intermediates
Expansion of specialty chemical manufacturing capacity
Rising export contributions to overall revenue
Focus on operational efficiency and cost optimization
These factors are expected to support the company’s long-term growth outlook.
| Investor Type | Holding (%) |
|---|---|
| Promoters | 45.22% |
| Retail & Others | 24.63% |
| Mutual Funds | 21.46% |
| Foreign Institutions | 6.15% |
| Other Domestic Institutions | 2.54% |
The shareholding pattern indicates strong promoter confidence along with healthy participation from mutual funds and foreign institutional investors.
| Year | Minimum Target (₹) | Maximum Target (₹) |
|---|---|---|
| 2026 | 650 | 720 |
| 2027 | 740 | 820 |
| 2028 | 830 | 920 |
| 2029 | 930 | 1,030 |
| 2030 | 1,050 | 1,180 |
These projections consider the company’s expansion plans, global demand for specialty chemicals, and increasing contribution from nutrition and life science segments.
By 2026, the company may benefit from improved demand across pharmaceutical and specialty chemical industries.
Growth Drivers
Rising demand for specialty chemical intermediates
Expansion of global export markets
Increasing applications in pharmaceutical manufacturing
Operational efficiency improvements
Investment View
Suitable for medium-term investors seeking exposure to India’s specialty chemical sector.
The company may experience stronger revenue growth as specialty chemicals continue to gain importance in global supply chains.
Growth Drivers
Expansion of specialty chemical production capacity
Growth in life science chemical demand
Stronger export opportunities
Increasing global outsourcing of chemical manufacturing to India
Investment View
Long-term investors may benefit from the sector’s structural growth.
By 2028, Jubilant Ingrevia may strengthen its global position as a specialty chemical supplier.
Growth Drivers
Rising demand for nutrition and health ingredients
Expansion of specialty intermediates for pharmaceuticals
Stronger operational margins due to economies of scale
Increased research and development investments
Investment View
A potentially attractive opportunity for investors looking at long-term chemical sector growth.
As the company continues expanding its product portfolio, revenue diversification may support stable growth.
Growth Drivers
Growing global demand for sustainable chemical solutions
Expansion of high-margin specialty products
Strong international partnerships and contracts
Increased demand from pharmaceutical and agrochemical sectors
Investment View
Long-term investors may see consistent value creation if the company maintains strong execution.
By 2030, Jubilant Ingrevia could become a stronger global supplier in specialty chemicals and nutrition ingredients.
Growth Drivers
Increasing global demand for specialty chemicals
Expansion of nutrition and life science product segments
Technological advancements in chemical manufacturing
Strong global supply chain integration
Investment View
Potentially suitable for long-term wealth creation in the chemical sector.
Jubilant Ingrevia Ltd operates in a sector that is expected to grow significantly as global chemical manufacturing increasingly shifts toward India.
Key Reasons to Consider Investment
Strong growth potential in specialty chemicals
Diversified product portfolio across industries
Increasing export opportunities
Strong promoter holding and institutional interest
Expansion in nutrition and life science segments
Risks to Watch
Volatility in raw material prices
Cyclical demand in chemical industries
Global economic slowdown affecting exports
Environmental and regulatory compliance requirements
Investors should closely monitor quarterly earnings, capacity expansion projects, and sector demand trends before making long-term investment decisions.
Jubilant Ingrevia Ltd has established itself as a strong participant in India’s specialty chemicals and nutrition ingredients industry. With growing global demand, expanding product lines, and increasing export opportunities, the company has strong long-term growth potential.
Based on current market data and industry trends, analysts estimate that the stock could reach between ₹1,050 and ₹1,180 by 2030.
For investors looking to gain exposure to India’s rapidly growing specialty chemical sector, Jubilant Ingrevia Ltd may offer a promising long-term investment opportunity.
1. What is the current share price of Jubilant Ingrevia Ltd?
The stock currently trades around the values listed in the latest market data table and changes depending on market activity.
2. What is the share price target for 2026?
The expected share price target for 2026 is between ₹650 and ₹720.
3. Is Jubilant Ingrevia Ltd a good long-term investment?
It may be considered for long-term investment due to its presence in the fast-growing specialty chemicals sector.
4. What is the share price target for 2030?
The projected share price target for 2030 is between ₹1,050 and ₹1,180.
5. What factors influence the stock price of Jubilant Ingrevia Ltd?
Demand for specialty chemicals, export growth, raw material costs, sector demand, and overall market sentiment play a major role in determining the stock price.
Disclaimer: This article is for educational purposes only. Please consult a financial advisor before making investment decisions.
